According to the publisher, Europe Biopsy Devices Market will reach US$ 996.3 Million in 2027. A biopsy is a medical operation that removes tissues or cells from the organs to aid in examining disorders. Surgeons, radiologists, cardiologists, and other medical professionals undertake the procedure using biopsy devices. These devices are made to remove diagnostic-quality specimens while minimizing crush artifacts and tissue fragmentation. Biopsy guiding systems, needle-based biopsy guns, biopsy needles, and biopsy forceps are the most often used biopsy instruments. They are being used in a wide range of healthcare settings throughout Europe, including medical clinics, diagnostic facilities, and hospitals.Europe Biopsy Devices Market reached US$ 667.6 Billion in 2021
Europe Biopsy Devices Market Size is likely to expand at a CAGR of 6.90% during 2021-2027
Increased investments in R&D activities are driving the Europe Biopsy Devices Market. For example, the European Union's Horizon 2020 initiative awarded €6.3 million for MRI research and liquid biopsy research. Furthermore, increased public awareness regarding biopsy procedures and screening tests contributes to the region's market growth. Moreover, healthcare professionals concentrate on minimally invasive (MI) biopsy technologies, expected to boost the market growth.Needle-based Biopsy Instruments are Expected to Hold a Major Market Share
By Product, needle-based biopsy has the largest market share due to the rising demand for equipment for obtaining samples from soft tissues of internal organs such as the breasts, kidneys, and lungs. Hence, the factor above is expected to contribute to the overall market's growth during the projected period. Furthermore, the growing demand for Fine Aspiration Needles and Core Needles for obtaining samples from soft tissues of internal organs, including the breasts, prostate, and lungs, is propelling the market forward.By Imaging Technology, CT scan, Stereotactic Guided, Ultrasound Guided, and MRI Guided are all utilized extensively in treating breast cancer, lung cancer, and prostate cancer across a wide range of end-users, including diagnostic centers and hospitals. Furthermore, enhanced healthcare infrastructure and the rising occurrence of infections have boosted the growth of biopsy instruments over the forecast period. This is due to the expansion of the healthcare sector in emerging economies, increased out-of-pocket healthcare spending, and the number of hospitals.
Regional Analysis - Germany is the leading contributor to the Europe Biopsy Devices Industry
In Europe, Germany is the top contributor to the biopsy device market. It's because of the high number of qualified medical experts, well-developed infrastructure, and the presence of the majority of essential stakeholders. Furthermore, France is an attractive site for medical device producers. The rapid improvement of healthcare infrastructure in emerging France, combined with high unmet patient requirements and rising breast cancer incidence, is expected to boost demand for biopsy devices.Competitive Landscape
The Biopsy Devices Market in Europe is very competitive. Becton, Dickinson and Company, Thermo Fisher Scientific Inc, Bio-Rad Laboratories, Exact Sciences (Genomic Health), Biocept, Biocartis, Roche Diagnostics, Myriad Genetics Inc., Qiagen, NeoGenomics Laboratories, and Quest Diagnostics Inc. are the leading market competitors in the biopsy devices industry. To benefit the sector, these companies are pursuing methods such as product introduction through technological advancements and alliances. New product launches are the most favored strategy for market capitalization, followed by collaborations and geographic expansion.How COVID-19 Affected the Europe Biopsy Devices Industry
The Coronavirus outbreak damaged the European biopsy diagnostics centers, hospitals, supply chains, and clinical trials. Cancer diagnoses were being delayed since diagnosis services and screening programs had been halted since the beginning of the COVID-19 outbreak. Cancer patients had numerous obstacles outside of the pandemic, including increased susceptibility to severe infection and disruptions in treatment or routine medical care. According to our analysis, the Europe Biopsy Devices Market was negatively impacted from the end of 2019 to the beginning of 2020. According to our estimates, Europe Biopsy Devices Market reached US$ 667.6 Billion in 2021 post recovery from the pandemic scenario.The publisher's latest report “Europe Biopsy Devices Market, Forecast By Product (Needle Based, Biopsy Forceps, Localization Wire, Others), Imaging Technology (CT scan, Stereotactic Guided, Ultrasound Guided, MRI Guided and Others), Country (United Kingdom, France, Germany, Italy, Spain, Russia and Rest of Europe), End-User (Diagnostic Centers, Hospitals and Others), Application (Cancer Type) (Breast Cancer, Lung Cancer, Prostate Cancer and Others), Companies (Becton, Dickinson and Company, Thermo Fisher Scientific Inc, Bio-Rad Laboratories, Exact Sciences (Genomic Health), Biocept, Biocartis, Roche Diagnostics, Myriad Genetics Inc., Qiagen, NeoGenomics Laboratories, and Quest Diagnostics Inc.)” provides a detailed analysis of Europe Biopsy Devices Industry.
Product - The market has been studied from 4 viewpoints
1. Needle Based2. Biopsy Forceps
3. Localization Wire
4. Others
Imaging Technology - The market has been studied from 5 viewpoints
1. CT scan2. Stereotactic Guided
3. Ultrasound Guided
4. MRI Guided
5. Others
Country - The market has been studied from 7 viewpoints
1. United Kingdom2. France
3. Germany
4. Italy
5. Spain
6. Russia
7. Rest of Europe
End-User - The market has been studied from 3 viewpoints
1. Diagnostic Centers2. Hospitals
3. Others
Application (Cancer Type) - The market has been studied from 4 viewpoints
1. Breast Cancer2. Lung Cancer
3. Prostate Cancer
4. Others
Company Insights
- Overview
- Initiatives/Recent Developments
- Financial Insight
Companies Covered
1. Becton, Dickinson and Company2. Thermo Fisher Scientific Inc
3. Bio-Rad Laboratories
4. Exact Sciences (Genomic Health)
5. Biocept
6. Biocartis
7. Roche Diagnostics
8. Myriad Genetics Inc.
9. Qiagen
10. NeoGenomics Laboratories
11. Quest Diagnostics Inc.
Table of Contents
Companies Mentioned
- Becton, Dickinson and Company
- Thermo Fisher Scientific Inc
- Bio-Rad Laboratories
- Exact Sciences (Genomic Health)
- Biocept
- Biocartis
- Roche Diagnostics
- Myriad Genetics Inc.
- Qiagen
- NeoGenomics Laboratories
- Quest Diagnostics Inc.
Methodology
In this report, for analyzing the future trends for the studied market during the forecast period, the publisher has incorporated rigorous statistical and econometric methods, further scrutinized by secondary, primary sources and by in-house experts, supported through their extensive data intelligence repository. The market is studied holistically from both demand and supply-side perspectives. This is carried out to analyze both end-user and producer behavior patterns, in the review period, which affects price, demand and consumption trends. As the study demands to analyze the long-term nature of the market, the identification of factors influencing the market is based on the fundamentality of the study market.
Through secondary and primary researches, which largely include interviews with industry participants, reliable statistics, and regional intelligence, are identified and are transformed to quantitative data through data extraction, and further applied for inferential purposes. The publisher's in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of their recommendations and advice.
Primary Research
The primary purpose of this phase is to extract qualitative information regarding the market from the key industry leaders. The primary research efforts include reaching out to participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions. The publisher also established professional corporate relations with various companies that allow us greater flexibility for reaching out to industry participants and commentators for interviews and discussions, fulfilling the following functions:
- Validates and improves the data quality and strengthens research proceeds
- Further develop the analyst team’s market understanding and expertise
- Supplies authentic information about market size, share, growth, and forecast
The researcher's primary research interview and discussion panels are typically composed of the most experienced industry members. These participants include, however, are not limited to:
- Chief executives and VPs of leading corporations specific to the industry
- Product and sales managers or country heads; channel partners and top level distributors; banking, investment, and valuation experts
- Key opinion leaders (KOLs)
Secondary Research
The publisher refers to a broad array of industry sources for their secondary research, which typically includes, however, is not limited to:
- Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
- Patent and regulatory databases for understanding of technical & legal developments
- Scientific and technical writings for product information and related preemptions
- Regional government and statistical databases for macro analysis
- Authentic new articles, webcasts, and other related releases for market evaluation
- Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecasts
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 180 |
| Published | September 2022 |
| Forecast Period | 2021 - 2027 |
| Estimated Market Value ( USD | $ 667.6 Million |
| Forecasted Market Value ( USD | $ 996.3 Million |
| Compound Annual Growth Rate | 6.9% |
| Regions Covered | Europe |
| No. of Companies Mentioned | 11 |
